Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease

Author list available on linked original paper · 2021 · Pharmaceuticals 14(6):515

Animal / experimentalFull text availableSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

Investigates EDR and KED in an experimental Alzheimer’s model, including dendritic-spine and neuroplasticity measures. Animal-model findings do not establish human benefit.

Population and setting: 5xFAD mouse model and neuronal research
Evidence type: Animal / experimental
Preparation: See the original report; formulation details require verification.
Source language: English
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Animal disease model, not a healthy-person or clinical trial.
No effect size is entered without complete methods and endpoint review.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Source scope and bibliographic record checked; underlying experiments require individual appraisal.

Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.3390/ph14060515

Cite and trace this record

Original source: Author list available on linked original paper. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease Pharmaceuticals 14(6):515 2021.

Molekul research summary: https://molekul.io/research/edr-ked-2021. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Pinealon

A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.

KED

A tripeptide research entry connected to experimental neurodegeneration work. No human benefit is inferred from mouse-model findings.

Editorial policy and evidence standards